UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns

Blood, 2019-08, Vol.134 (5), p.415-420

2019

Volltextzugriff (PDF)

Cardiovascular Disease and Stroke in Immune TTP-Challenges and Opportunities

Journal of clinical medicine, 2023-09, Vol.12 (18), p.5961

2023

Volltextzugriff (PDF)

Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

British journal of haematology, 2014-03, Vol.164 (6), p.900-902

2014

Volltextzugriff (PDF)

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

Blood advances, 2018-08, Vol.2 (16), p.2136-2144

2018

Volltextzugriff (PDF)

Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange

Therapeutic apheresis and dialysis, 2018-12, Vol.22 (6), p.662-665

2018

Volltextzugriff (PDF)

The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students

Blood Research, 2019, 54(2), , pp.125-130

2019

Volltextzugriff (PDF)

Men with severe hemophilia in the United States: birth cohort analysis of a large national database

Blood, 2016-06, Vol.127 (24), p.3073-3081

2016

Volltextzugriff (PDF)

Race, rituximab, and relapse in TTP

Blood, 2022-09, Vol.140 (12), p.1335-1344

2022

Volltextzugriff (PDF)

Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura

Annals of hematology, 2022-10, Vol.101 (10), p.2159-2167

2022

Volltextzugriff (PDF)

Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpura

American journal of hematology, 2021-12, Vol.96 (12), p.1587-1594

2021

Volltextzugriff (PDF)

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients

Transfusion (Philadelphia, Pa.), 2020-08, Vol.60 (8), p.1676-1680

2020

Volltextzugriff (PDF)

Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies

Transfusion medicine reviews, 2019-10, Vol.33 (4), p.248-255

2019

Volltextzugriff (PDF)

Opioid exposure in haemophilia patients is common and underreported

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-03, Vol.26 (2), p.251-256

2020

Volltextzugriff (PDF)

The Impact of an Undergraduate Biology Class on Donor Recruitment at a Hospital-Based Blood Donor Center

American journal of clinical pathology, 2020-02, Vol.153 (3), p.368-373

2020

Volltextzugriff (PDF)

Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise

Journal of clinical apheresis, 2018-06, Vol.33 (3), p.291-296

2018

Volltextzugriff (PDF)

How we approach an acquired thrombotic thrombocytopenic purpura patient

Transfusion (Philadelphia, Pa.), 2014-10, Vol.54 (10), p.2375-2382

2014

Volltextzugriff (PDF)

Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass?

Journal of clinical apheresis, 2020-06, Vol.35 (3), p.236-237

2020

Volltextzugriff (PDF)

Pathology consultation on electronic crossmatch

American journal of clinical pathology, 2014-05, Vol.141 (5), p.618-624

2014

Volltextzugriff (PDF)

Heparin‐induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis

Journal of clinical apheresis, 2020-01, Vol.35 (1), p.59-61

2020

Volltextzugriff (PDF)

Monitoring therapeutic apheresis utilization: Database versus registry

Journal of clinical apheresis, 2017-06, Vol.32 (3), p.208-209

2017

Volltextzugriff (PDF)

Rainbow of hemolysis associated with acquired thrombotic thrombocytopenic purpura

Journal of clinical apheresis, 2017-08, Vol.32 (4), p.274-275

2017

Volltextzugriff (PDF)

Two cases of asymptomatic massive fetomaternal hemorrhage

Transfusion and apheresis science, 2015-04, Vol.52 (2), p.208-210

2015

Volltextzugriff (PDF)

Plasma Exchange Taper for Acquired TTP Is Protective Against Recurrence at Both 30 Days and 6 Months: A Retrospective Study from 2 Academic Medical Centers

Blood, 2015-12, Vol.126 (23), p.1046-1046

2015

Volltextzugriff (PDF)

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Blood, 2017-12, Vol.130, p.1049-1049

2017

Volltextzugriff (PDF)

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Blood, 2017-12, Vol.130, p.3620-3620

2017

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Hematology
(30)
Humans
(25)
Adult
(8)
Female
(8)
Male
(8)
Middle Aged
(7)
Thrombotic Thrombocytopenic Purpura
(7)
Adamts13 Protein
(6)
Recurrence
(5)
Apheresis
(4)
General & Internal Medicine
(4)
Medicine, General & Internal
(4)
Purpura, Thrombotic Thrombocytopenic - Therapy
(4)
Thrombocytopenic Purpura
(4)
Thrombosis
(4)
Adolescent
(3)
Aged
(3)
Bortezomib
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns

Cardiovascular Disease and Stroke in Immune TTP-Challenges and Opportunities

Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange

The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students

Men with severe hemophilia in the United States: birth cohort analysis of a large national database

Race, rituximab, and relapse in TTP

Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura

Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpura

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients

Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies

Opioid exposure in haemophilia patients is common and underreported

The Impact of an Undergraduate Biology Class on Donor Recruitment at a Hospital-Based Blood Donor Center

Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise

How we approach an acquired thrombotic thrombocytopenic purpura patient

Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass?

Pathology consultation on electronic crossmatch

Heparin‐induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis

Monitoring therapeutic apheresis utilization: Database versus registry

Rainbow of hemolysis associated with acquired thrombotic thrombocytopenic purpura

Two cases of asymptomatic massive fetomaternal hemorrhage

Plasma Exchange Taper for Acquired TTP Is Protective Against Recurrence at Both 30 Days and 6 Months: A Retrospective Study from 2 Academic Medical Centers

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Suchergebnisse filtern